Literature DB >> 27160052

Identification of selective covalent inhibitors of platelet activating factor acetylhydrolase 1B2 from the screening of an oxadiazolone-capped peptoid-azapeptoid hybrid library.

Bani Kanta Sarma1, Xiaodan Liu2, Thomas Kodadek2.   

Abstract

A potent and selective inhibitor of platelet-activating factor acetylhydrolase 1B2 (PAFAH1B2) is described. The compound was derived by improvement of a modest affinity primary hit isolated from the screening of a bead-displayed peptoid-azapeptoid hybrid library tethered to an oxadiazolone 'warhead'. The oxadiazolone moiety of the inhibitors was found to react covalently with the active site serine residue of PAFAH1B2. This screening strategy may be useful for the identification of many selective, covalent inhibitors of serine hydrolases.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Combinatorial chemistry; High throughput screening; PAFAH1B2; Peptoid; Serine hydrolase

Mesh:

Substances:

Year:  2016        PMID: 27160052      PMCID: PMC4972644          DOI: 10.1016/j.bmc.2016.04.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  47 in total

Review 1.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 2.  Covalent modifiers: an orthogonal approach to drug design.

Authors:  Michele H Potashman; Mark E Duggan
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

3.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

Review 4.  Covalent protein modification: the current landscape of residue-specific electrophiles.

Authors:  D Alexander Shannon; Eranthie Weerapana
Journal:  Curr Opin Chem Biol       Date:  2014-11-11       Impact factor: 8.822

Review 5.  Crystallographic and NMR studies of the serine proteases.

Authors:  T A Steitz; R G Shulman
Journal:  Annu Rev Biophys Bioeng       Date:  1982

6.  Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors.

Authors:  K Brady; A Z Wei; D Ringe; R H Abeles
Journal:  Biochemistry       Date:  1990-08-21       Impact factor: 3.162

7.  Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.

Authors:  David E Ehmann; Haris Jahić; Philip L Ross; Rong-Fang Gu; Jun Hu; Gunther Kern; Grant K Walkup; Stewart L Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

8.  Inhibition of serine proteases by peptidyl fluoromethyl ketones.

Authors:  B Imperiali; R H Abeles
Journal:  Biochemistry       Date:  1986-07-01       Impact factor: 3.162

9.  Inhibition of papain by nitriles: mechanistic studies using NMR and kinetic measurements.

Authors:  T C Liang; R H Abeles
Journal:  Arch Biochem Biophys       Date:  1987-02-01       Impact factor: 4.013

10.  Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors.

Authors:  Alexander Adibekian; Brent R Martin; Chu Wang; Ku-Lung Hsu; Daniel A Bachovchin; Sherry Niessen; Heather Hoover; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2011-05-15       Impact factor: 15.040

View more
  2 in total

1.  Synthesis of acylhydrazino-peptomers, a new class of peptidomimetics, by consecutive Ugi and hydrazino-Ugi reactions.

Authors:  Angélica de Fátima S Barreto; Veronica Alves Dos Santos; Carlos Kleber Z Andrade
Journal:  Beilstein J Org Chem       Date:  2016-12-27       Impact factor: 2.883

2.  Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.

Authors:  Agata Zięba; Tuomo Laitinen; Jayendra Z Patel; Antti Poso; Agnieszka A Kaczor
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.